FMP
Entera Bio Ltd.
ENTX
NASDAQ
Entera Bio Ltd., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of orally delivered large molecule therapeutics for unmet medical needs. The company's lead product candidates include the EB612, which is in Phase II clinical trials for the treatment of hypoparathyroidism; and EB613 that has completed Phase II clinical trials for the treatment of osteoporosis, as well as is in Phase I clinical trials for the treatment of non-union fractures. The company has a research collaboration and license agreement with the Amgen Inc. for the development and discovery of clinical candidates in the field of inflammatory disease and other serious illnesses. Entera Bio Ltd. was incorporated in 2009 and is based in Jerusalem, Israel.
1.99 USD
-0.25 (-12.56%)
About
ceo
Ms. Miranda J. Toledano M.B.A.
sector
Healthcare
industry
Biotechnology
website
https://www.enterabio.com
exchange
NASDAQ
Description
Entera Bio Ltd., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of orally delivered large molecule therapeutics for unmet medical needs. The company's lead product candidates include the EB612, which is in Phase II clinical trials for the treatment of hypoparathyroidism; and EB613 that has completed Phase II clinical trials for the treatment of osteoporosis, as well as is in Phase I clinical trials for the treatment of non-union fractures. The company has a research collaboration and license agreement with the Amgen Inc. for the development and discovery of clinical candidates in the field of inflammatory disease and other serious illnesses. Ente...
CIK
0001638097
ISIN
IL0011429839
CUSIP
M40527109
Address
Kiryat Hadassah Minrav Buildin...
Phone
972 2 532 7151
Country
IL
Employee
17
IPO Date
Jun 28, 2018
Summary
CIK
0001638097
Exchange
NASDAQ
Industry
Biotechnology
Sector
Healthcare
CUSIP
M40527109
ISIN
IL0011429839
Country
IL
Price
1.99
Beta
1.71
Volume Avg.
222.99k
Market Cap
70.61M
Shares
-
52-Week
0.52-3.35
DCF
0.37
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
-6.42
P/B
-
Website
https://www.enterabio.com
Historical Prices
We are unable to load the chart at this time.
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
Upgrades and Downgrades
We are unable to load this data!
People Also Watch
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest ENTX News
It looks like there's no news available.
